Skip to main content
SpringerLink
Log in

Dopaminergic supersensitivity after neuroleptics: Time-course and specificity

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

It is known that a single dose of a neuroleptic can elicit dopaminergic supersensitivity in animals. On the other hand, the clinical syndrome of tardive dyskinesia takes many months or years to develop. To resolve this apparent discrepancy, it is possible that subclinical or latent tardive dyskinesia is fully compensated in most patients taking neuroleptics. In others, where the tardive dyskinesia is full-blown and grossly apparent, the dopaminergic supersensitivity may be decompensated. Such compensatory and decompensatory phases have been proposed earlier by Hornykiewicz (1974), in the case of Parkinson's Disease.

Dopaminergic supersensivity persists for a period proportional to the length of the neuroleptic treatment. It is not yet clear whether the relation between the length of treatment and the persistence of supersensitivity holds for very long treatments but in principle the relationship might account for the persistence of tardive dyskinesia after years of neuroleptic pretreatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ahtee, L., Kaariainen, I.: The effect of narcotic analgesics on the homovanillic acid content of rat nucleus caudatus. Eur. J. Pharmacol. 22, 216–218 (1973)

    Google Scholar 

  • Ahtee, L.: Catalepsy and stereotypies in the rats treated with methadone: relation to striatal dopamine. Eur. J. Pharmacol. 27, 221–230 (1974)

    Google Scholar 

  • Anden, N.-E., Butcher, S. G., Corrodi, H., Fuxe, K., Ungerstedt, U.: Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur. J. Pharmacol. 11, 303–314 (1970)

    Google Scholar 

  • Asper, H., Baggiolini, M., Burki, H. R., Lauener, H., Ruch, W., Stille, G.: Tolerance phenomena with neuroleptics. Catalepsy apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol. Eur. J. Pharmacol. 22, 287–294 (1973)

    Google Scholar 

  • Bowers, M. B., Jr., Rozitis, A.: Regional differences in homovanillic acid concentrations after acute and chronic administration of antipsychotic drugs. J. Pharm. Pharmacol. 26, 743–745 (1974)

    Google Scholar 

  • Burkard, W. P., Bartholini, G.: Changes in activation of adenylate cyclase and of dopamine turnover in rat striatum during prolonged haloperidol treatment. Experimentia 30, 685 (1974)

    Google Scholar 

  • Burt, D. R., Creese, I., Snyder, S. H.: Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 196, 326–328 (1977)

    Google Scholar 

  • Burt, D. R., Enna, S. J., Creese, I., Snyder, S. H.: Dopamine receptor binding in the corpus striatum of mammalian brain. Proc. Natl. Acad. Sci. U.S.A. 72, 4655–4659 (1975)

    Google Scholar 

  • Carlsson, A.: Receptor-mediated control of dopamine metabolism. In: Pre- and postsynaptic receptors. E. Usdin and W. E. Bunney, eds., pp. 49–63. New York: Marcel Dekker 1975

    Google Scholar 

  • Christensen, A. V., Fjalland, B., Møller Nielsen, I.: On the supersensitivity of dopamine receptors induced by neuroleptics. Psychopharmacology 48, 1–6 (1976)

    Google Scholar 

  • Clouet, D. H., Iwatsubo, K.: Dopamine-sensitive adenylate cyclase of the caudate nucleus of rats treated with morphine. Life Sci. 17, 35–40 (1975)

    Google Scholar 

  • Costall, B., Naylor, R. J.: Neuroleptic and non-neuroleptic catalepsy. Arzneim. Forsch. 23, 674–683 (1973)

    Google Scholar 

  • Costall, B., Naylor, R. J.: The behavioural effects of dopamine applied intracerebrally to areas of mesolimbic system. Eur. J. Pharmacol. 32, 87–92 (1975)

    Google Scholar 

  • Costentin, J., Marcais, H., Protais, P., Baudry, M., Delabaume, S., Matres, M. P., Schwartz, J. C.: Rapid development of hypersensitivity of striatal dopamine receptors induced by alfamethylparatyrosine and its prevention by protein synthesis inhibitors. Life Sci. 21, 307–314 (1977)

    Google Scholar 

  • Cox, B., Ary, M., Lomax, P.: Changes in sensitivity to apomorphine during morphine dependence and withdrawal in rats. J. Pharmacol. Exp. Ther. 196, 637–641 (1975)

    Google Scholar 

  • Crane, G. E.: Persistent dyskinesia. Br. J. Psychiatry 122, 395–405 (1973)

    Google Scholar 

  • Creese, I., Iversen, S. D.: The role of forebrain dopamine systems in amphetamine induced stereotyped behaviour in the rat. Psychopharmacologia (Berl.) 39, 345–357 (1974)

    Google Scholar 

  • Dolphin, A., Sawaya, M. C. B., Jenner, P., Marsden, C. D.: Behavioural and biochemical effects of chronic reduction of cerebral noradrenaline receptor stimulation. Naunyn-Schmiedeberg's Arch. Pharmacol. 299, 163–173 (1977)

    Google Scholar 

  • Dustan, R., Jackson, D. M.: The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol. Psychopharmacology 38, 105–114 (1976)

    Google Scholar 

  • Dustan, R., Jackson, D. M.: The demonstration of a change in responsiveness of mice to physostigmine and atropine after withdrawal from long-term haloperidol pretreatment. J. Neural Transm. 40, 181–189 (1977)

    Google Scholar 

  • Engel, J., Liljequist, S.: The effect of long-term ethanol treatment on the sensitivity of the dopamine receptors in the nucleus accumbens. Psychopharmacology 49, 253–257 (1976)

    Google Scholar 

  • Ezrin-Waters, C., Muller, P., Seeman, P.: Catalepsy induced by morphine or haloperidol effects of apomorphine and anticholinergic drugs. Can. J. Physiol. Pharmacol. 54, 516–519 (1976)

    Google Scholar 

  • Ezrin-Waters, C., Seeman, P.: Tolerance to haloperidol catalepsy. Eur. J. Pharmacol. 41, 321–327 (1977)

    Google Scholar 

  • Ezrin-Waters, C., Seeman, P.: Haloperidol-induced tolerance to morphine catalepsy. Life Sci. 21, 419–422 (1977)

    Google Scholar 

  • Friedhoff, A. J., Bonnet, K., Rosengarten, H.: Reversal of two manifestations of dopamine receptor supersensitivity by administration of L-DOPA. Res. Commun. Chem. Pathol. Pharmacol. 16, 411–423 (1977)

    Google Scholar 

  • Fukui, K., Takagi, H.: Effect of morphine on cerebral contents of metabolites of dopamine in the normal and tolerant mice: its possible relation to analgesic action. Br. J. Pharmacol. 44, 45–51 (1972)

    Google Scholar 

  • Fuxe, K.: Tools in the treatment of Parkinson's disease: studies on new types of dopamine receptor stimulating agents. In: Progress in the treatment of Parkinsonism. Advances in neurology, Vol. 3, D. B. Calne, ed., pp. 273–279. New York: Raven 1973

    Google Scholar 

  • Gessa, G. L., Tagliamonte, A.: Effect of methadone and dextromoramide on dopamine metabolism: comparison with haloperidol and amphetamine. Neuropharmacology 14, 913–920 (1975)

    Google Scholar 

  • Gianutsos, G., Drawbaugh, R. B., Hynes, M. D., Lal, H.: Behavioural evidence for dopaminergic supersensitivity after chronic haloperidol. Life Sci. 14, 887–898 (1974)

    Google Scholar 

  • Gianutsos, G., Lal, H.: Alteration in the action of cholinergic and anticholinergic drugs after chronic haloperidol: indirect evidence for cholinergic hyposensitivity. Life Sci. 18, 515–520 (1976)

    Google Scholar 

  • Gianutsos, G., Thornburg, J. E., Moore, K. E.: Differential actions of dopamine agonists and antagonists on γ-butyrolactone-induced increase in mouse brain dopamine. Psychopharmacology 50, 225–229 (1976)

    Google Scholar 

  • Gianutsos, G., Moore, K. E.: Dopaminergic supersensitivity in striatum and olfactory tubercle following chronic administration of haloperidol or clozapine. Life Sci. 20, 1585–1592 (1977)

    Google Scholar 

  • Gnegy, M., Uzunov, P., Costa, E.: Participation of an endogenous Ca++-binding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors. J. Pharmacol. Exp. Ther. 202, 558–564 (1977)

    Google Scholar 

  • Griffiths, P. J., Littleton, J. M., Ortiz, A.: Changes in monoamine concentrations in mouse brain associated with ethanol dependence and withdrawal. Br. J. Pharmacol. 50, 489–494 (1974)

    Google Scholar 

  • György, L., Pfeifer, K. A., Hajtman, B.: Modification of certain central nervous effects of haloperidol during long-term treatment in the mouse and rat. Psychopharmacologia (Berl.) 16, 223–233 (1969)

    Google Scholar 

  • Heal, D. J., Green, A. R., Boullin, D. J., Graham-Smith, D. G.: Single and repeated administration of neuroleptic drugs to rats: effect on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and l-tryptophan or l-dopa. Psychopharmacology 49, 287–300 (1976)

    Google Scholar 

  • Hicks, J., Strong, R., Smith, R. C., Samorajski, T.: Behavioural supersensitivity to bromocriptine in mice. Society for Neuroscience abstract, III, p. 441, No. 1406 (1977)

  • Hoffman, P. L., Tabakoff, B.: Alterations in dopamine receptor sensitivity by chronic ethanol treatment. Nature 268, 551–552 (1977)

    Google Scholar 

  • Hornykiewicz, O.: The mechanisms of action of L-DOPA in Parkinson's disease. Life Sci. 15, 1249–1259 (1974)

    Google Scholar 

  • Iwatsubo, K., Clouet, D. H.: Dopamine-sensitive adenylate cyclase of the caudate nucleus of rats treated with morphine or haloperidol. Biochem. Pharmacol. 24, 1499–1503 (1975)

    Google Scholar 

  • Jackson, D. M., Andén, N.-E., Engel, J., Liljequist, S.: The effect of long-term penfluridol treatment on the sensitivity of the dopamine receptors in the nucleus accumbens and the corpus striatum. Psychopharmacologia (Berl.) 45, 151–155 (1975)

    Google Scholar 

  • Jackson, D. M., Andén, N.-E., Dahlström, A.: A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain. Psychopharmacologia (Berl.) 45, 139–149 (1975)

    Google Scholar 

  • Keller, H. H., Bartholini, G., Pletscher, A.: Increase of 3-methoxy-4-hydroxyphenylethylene glycol in rat brain by neuroleptic drugs. Eur. J. Pharmacol. 23, 183–186 (1973)

    Google Scholar 

  • Klawans, H. L., Crossett, P., Dana, N.: Effect of chronic amphetamine exposure on stereotyped behaviour: implications for pathogenesis of L-Dopa-induced dyskinesias. In: Dopaminergic mechanisms. Advances in neurology, Vol. 9, D. Calne, T. N. Chase and A. Barbeau, eds., pp. 105–112, New York: Raven 1975

    Google Scholar 

  • Klawans, H. L., Margolin, D. I.: Amphetamine-induced dopaminergic hypersensitivity in guinea-pigs. Arch. Gen. Psychiatry 32, 725–732 (1975)

    Google Scholar 

  • Klawans, H. L., Goetz, C., Nausieda, P. A., Weiner, W. J.: Levodopa-induced dopamine receptor hypersensitivity. Ann. Neurology 2, 125–129 (1977)

    Google Scholar 

  • Kobayashi, R. M., Fields, J. Z., Hruska, R. E., Beaumont, K., Yamamura, H. I.: Brain neurotransmitter receptors and chronic antipsychotic drug treatment: a model for tardive dyskinesia. In: Animal models in psychiatry. E. Usdin, ed. pp. 405–409. New York: Pergamon 1978

    Google Scholar 

  • Kuschinsky, K., Hornykiewicz, O.: Morphine catalepsy in rat: relation to striatal dopamine metabolism. Eur. J. Pharmacol. 19, 119–122 (1972)

    Google Scholar 

  • Kuschinsky, K.: Dopamine receptor sensitivity after repeated morphine administrations to rats. Life Sci. 17, 43–48 (1975)

    Google Scholar 

  • Lerner, P., Nosé, P.: Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnover. Science 197, 181–183 (1977)

    Google Scholar 

  • Leysen, J., Tollenaere, J. P., Koch, M. H. J., Laduron, P.: Differentiation of opiate and neuroleptic receptor binding in rat brain. Eur. J. Pharmacol. 43, 253–267 (1977)

    Google Scholar 

  • Marsden, C. D., Tarsy, D., Baldessarini, R. J.: Spontaneous and drug-induced movement disorders in psychotic patients. In: Psychiatric aspects of neurologic disease. D. F. Benson and D. Blumer, eds., pp. 219–265. New York: Grune & Stratton 1975

    Google Scholar 

  • Martres, M. P., Costentin, J., Baudry, M., Marcais, H., Protais, P., Schwartz, J. C.: Long-term changes in the sensitivity of pre- and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studies. Brain Res. 136, 319–337 (1977)

    Google Scholar 

  • Merali, Z., Singhal, R. L., Hrdina, P. D., Ling, G. M.: Changes in brain cyclic AMP metabolism and acetylcholine and dopamine during narcotic dependence and withdrawal. Life Sci. 16, 1889–1894 (1975)

    Google Scholar 

  • Møller Nielsen, I., Fjalland, B., Pedersen, V., Nymark, M.: Pharmacology of neuroleptics upon repeated administration. Psychopharmacologia (Berl.) 34, 95–104 (1974)

    Google Scholar 

  • Muller, P., Seeman, P.: Increased specific neuroleptic binding after chronic haloperidol in rats. Soc. Neurosci. Abstr. 2, 874 (1976)

    Google Scholar 

  • Muller, P., Seeman, P.: Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptors. Life Sci. 21, 1751–1758 (1977)

    Google Scholar 

  • Pijnenburg, A. J. J., Honing, W. M. M., Van Der Heyden, J. A. M., Van Rossum, J. M.: Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. Eur. J. Pharmacol. 35, 45–58 (1976)

    Google Scholar 

  • Puri, S. K., Lal, H.: Tolerance to the behavioural and neurochemical effects of haloperidol and morphine in rats chronically treated with morphine or haloperidol. Naunyn-Schmiedeberg's Arch. Pharmacol. 282, 155–170 (1974)

    Google Scholar 

  • Puri, S. K., Volicer, L., Cochin, J.: Changes in the striatal adenylate cyclase activity following acute and chronic morphine treatment and during withdrawal. J. Neurochem. 27, 1551–1554 (1976)

    Google Scholar 

  • Quitkin, F., Rifkin, A., Gochfeld, L., Klein, D. F.: Tardive dyskinesia: are first signs reversible? Am. J. Psychiatry 134, 84–87 (1977)

    Google Scholar 

  • Riffee, W. H., Gerald, M. C.: The effect of chronic administration and withdrawal of (+)-amphetamine on seizure threshold and endogenous catecholamine concentrations and their rates of biosynthesis in mice. Psychopharmacology 51, 175–179 (1977)

    Google Scholar 

  • Rotrosen, J., Friedman, E., Gershon, S.: Striatal adenylate cyclase activity following reserpine and chronic chlorpromazine administration in rats. Life Sci. 17, 563–568 (1975)

    Google Scholar 

  • Sasame, H. A., Perez-Cruet, J.: Evidence that methadone blocks dopamine receptors in the brain. J. Neurochem. 19, 1953–1957 (1972)

    Google Scholar 

  • Sayers, A. C., Bürki, H. R., Ruch, W. Asper, H.: Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine. Psychopharmacologia (Berl.) 41, 97–104 (1975)

    Google Scholar 

  • Scatton, B., Glowinski, J., Julou, L.: Dopamine metabolism in the mesolimbic and mesocortical dopaminergic systems after single or repeated administrations of the neuroleptics. Brain Res. 109, 184–189 (1976)

    Google Scholar 

  • Seeber, U., Kuschinsky, K.: Dopamine-sensitive adenylate cyclase in homogenates of rat striata during ethanol and barbiturate withdrawal. Arch. Toxicol. (Berl.) 35, 247–253 (1976)

    Google Scholar 

  • Seeman, P., Chau-Wong, M., Tedesco, J., Wong, K.: Brain receptors for antipsychotic drugs and dopamine: direct binding assays. Proc. Natl. Acad. Sci. U.S.A. 72, 4376–4380 (1975)

    Google Scholar 

  • Smith, R. C., Davis, J. M.: Behavioural evidence for supersensitivity after chronic administration of haloperidol, clozapine and thioridazine. Life Sci. 19, 725–732 (1976)

    Google Scholar 

  • Tang, L. C., Cotzias, G. C.: L-3,4-Dihydroxyphenylalanine-induced hypersensitivity simulating features of denervation. Proc. Natl. Acad. Sci. U.S.A. 74, 2126–2129 (1977)

    Google Scholar 

  • Tarsy, D., Baldessarini, R. J.: Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with synaptic function of catecholamines. Neuropharmacology 13, 927–940 (1974)

    Google Scholar 

  • Tarsy, D., Baldessarini, R. J.: The pathophysiologic basis of tardive dyskinesia. Biol. Psychiatry 12, 431–450 (1977)

    Google Scholar 

  • U'Prichard, D. C., Greenberg, D. A., Snyder, S. H.: Binding characteristics of radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors. Mol. Pharmacol. 13, 454–473 (1977)

    Google Scholar 

  • Von Stralendorff, V. B., Ackenheil, M., zimmermann, J.: Akute und chronische Wirkung von Carpipramin, Clozapin, Haloperidol und Sulpirid auf den Stoffwechsel biogener Amine im Rattengehirn. Arzneim. Forsch. 26, 1096–1098 (1976)

    Google Scholar 

  • Von Voigtlander, P. F., Losey, E. G., Triezenberg, H. J.: Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment. J. Pharmacol. Exp. Ther. 193, 88–94 (1975)

    Google Scholar 

  • Walters, J. R., Roth, R. H.: Dopamine neurons: an in vivo system for measuring drug interactions with presynaptic receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 296, 5–14 (1976)

    Google Scholar 

  • Worms, P., Scatton, B.: Tolerance to stereotyped behaviour and to decrease in striatal homovanillic acid levels after repeated treatment with apomorphine dipivaloyl ester. Eur. J. Pharmacol. 45, 395–396 (1977)

    Google Scholar 

  • Yarborough, G.: Supersensitivity of caudate neurones after repeated administration of haloperidol. Eur. J. Pharmacol. 31, 367–369 (1975)

    Google Scholar 

  • Zarcone, V., Barchas, J., Hoddes, E., Montplaisir, J., Sack, R., Wilson, R.: Experimental ethanol ingestion: sleep variables and metabolites of dopamine and serotonin in the cerebrospinal fluid. In: Alcohol intoxication and withdrawal. Vol. 2, M. M. Gross, ed., pp. 431–451. New York: Plenum 1975

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Faculty of Medicine, University of Toronto, M5S 1A8, Toronto, Ontario, Canada

    Pavel Muller & Philip Seeman

Authors
  1. Pavel Muller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philip Seeman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muller, P., Seeman, P. Dopaminergic supersensitivity after neuroleptics: Time-course and specificity. Psychopharmacology 60, 1–11 (1978). https://doi.org/10.1007/BF00429171

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00429171

Key words

Search

Navigation